- Home
- IMUX vs KOPN Comparison
IMUX vs KOPN Comparison
Compare IMUX & KOPN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMUX
- KOPN
- Stock Information
- Founded
- IMUX 2016
- KOPN 1984
- Country
- IMUX United States
- KOPN United States
- Employees
- IMUX N/A
- KOPN N/A
- Industry
- IMUX Biotechnology: Pharmaceutical Preparations
- KOPN Semiconductors
- Sector
- IMUX Health Care
- KOPN Technology
- Exchange
- IMUX Nasdaq
- KOPN Nasdaq
- Market Cap
- IMUX 67.8M
- KOPN 138.4M
- IPO Year
- IMUX N/A
- KOPN 1992
- Fundamental
- Price
- IMUX $0.70
- KOPN $1.56
- Analyst Decision
- IMUX Strong Buy
- KOPN Strong Buy
- Analyst Count
- IMUX 6
- KOPN 3
- Target Price
- IMUX $11.60
- KOPN $2.58
- AVG Volume (30 Days)
- IMUX 2.6M
- KOPN 3.1M
- Earning Date
- IMUX 08-07-2025
- KOPN 08-07-2025
- Dividend Yield
- IMUX N/A
- KOPN N/A
- EPS Growth
- IMUX N/A
- KOPN N/A
- EPS
- IMUX N/A
- KOPN N/A
- Revenue
- IMUX N/A
- KOPN $50,841,018.00
- Revenue This Year
- IMUX N/A
- KOPN $8.02
- Revenue Next Year
- IMUX N/A
- KOPN $20.99
- P/E Ratio
- IMUX N/A
- KOPN N/A
- Revenue Growth
- IMUX N/A
- KOPN 28.16
- 52 Week Low
- IMUX $0.56
- KOPN $0.56
- 52 Week High
- IMUX $2.11
- KOPN $2.17
- Technical
- Relative Strength Index (RSI)
- IMUX 36.49
- KOPN 56.76
- Support Level
- IMUX $0.68
- KOPN $1.55
- Resistance Level
- IMUX $0.77
- KOPN $1.70
- Average True Range (ATR)
- IMUX 0.07
- KOPN 0.09
- MACD
- IMUX -0.00
- KOPN -0.01
- Stochastic Oscillator
- IMUX 14.09
- KOPN 43.75
About IMUX Immunic Inc.
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.
About KOPN Kopin Corporation
Kopin Corp is a provider of high-performance application-specific optical solutions consisting of high-resolution microdisplays and optics, subassemblies, and headsets. It serves soldiers, avionics, armored vehicles training and simulation military applications, and others. Its product portfolio includes Microdisplays, Spatial Light Modulators, Optical Modules, Medical, Training, and Simulation. Geographically, it derives a majority of its revenue from the Americas and also has a presence in Asia-Pacific; Europe, and Other Countries.